शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans

This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →

BSEMICROSE INDIA LTD.· FinanceHighNeutral
Announced Wed, 4 Nov, 2026 · 18:56 IST

Standalone September 2026 quarter loss narrows; operating cash flow stays negative

Net loss reportedEmphasis of matterNegative operating cash flowDebt to equity above the thresholdResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction

Awaiting price reaction for this filing.

AI summary

For the standalone quarter ended 30 September 2026, revenue from operations was Rs 0.01 lakh versus negative Rs 1.55 lakh a year earlier; loss after tax was Rs 0.37 lakh versus Rs 8.86 lakh. Standalone half year ended 30 September 2026: loss after tax was Rs 3.32 lakh and operating cash flow was negative Rs 12.34 lakh. Reviewers flagged its non-banking financial company format without changing the conclusion.

Likely market impact

The quarterly loss narrowed, but continued losses and negative operating cash flow leave financial risk high and may weigh on the stock.

By the numbersStandalone · Q2 FY27 vs Q2 FY26
Q2 FY27Q2 FY26Change
Revenue₹0.00 Cr−₹0.02 Crloss narrowed
Operating profit−₹0.03 Cr−₹0.09 Crloss narrowed
Profit after tax−₹0.03 Cr−₹0.09 Crloss narrowed
EBITDA margin———

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.